Compare SCM & FOCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SCM | FOCL |
|---|---|---|
| Founded | 2012 | N/A |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 244.3M | 203.7M |
| IPO Year | 2012 | 1998 |
| Metric | SCM | FOCL |
|---|---|---|
| Price | $8.74 | $4.39 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | 174.1K | ★ 199.0K |
| Earning Date | 05-11-2026 | N/A |
| Dividend Yield | ★ 14.22% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.62 | N/A |
| Revenue | N/A | ★ $70,527,000.00 |
| Revenue This Year | $0.33 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $14.08 | ★ N/A |
| Revenue Growth | N/A | ★ 1.63 |
| 52 Week Low | $6.83 | $4.01 |
| 52 Week High | $14.85 | $6.40 |
| Indicator | SCM | FOCL |
|---|---|---|
| Relative Strength Index (RSI) | 59.38 | 35.06 |
| Support Level | $8.43 | $4.01 |
| Resistance Level | $8.97 | $5.64 |
| Average True Range (ATR) | 0.20 | 0.28 |
| MACD | 0.00 | -0.06 |
| Stochastic Oscillator | 48.94 | 15.59 |
Stellus Capital Investment Corp is a closed-end, non-diversified management investment company. Its objective is to maximize the total return to its stockholders in the form of current income and capital appreciation. It invests in private middle-market companies through first lien, second lien, and unsecured debt financing, often with a corresponding equity investment. The company invests in various sectors, such as business services, energy, general industrial, government services, healthcare, software, and specialty finance. The business activity of the firm functions throughout the United States, and it generates revenue in the form of interest income on debt investments, capital gains, and distributions.
Edap TMS SA, formerly known as FocalTherics, operates in the Robotic Focal Therapy industry. It develops, manufactures, and markets minimally invasive medical devices across various countries to treat various conditions using proprietary focused ultrasound technology. The company's flagship platform, Focal One Robotic HIFU, combines imaging, real-time treatment planning, robotic precision, and high intensity focused ultrasound (HIFU) technology. It is focused on expanding the clinical adoption of its patented focused ultrasound-based robotic therapy platforms through continued innovation, clinical evidence generation, physician education, and various market development initiatives.